Emend Merck - Treatment for Chemotherapy-Induced Nausea and Vomiting (CINV)
Emend is a P/neurokinin 1 (NK1) receptor antagonist used in
combination with other antiemetic agents to prevent and control
acute and delayed nausea and vomiting associated with initial and
repeat courses of highly emetogenic cancer chemotherapy.
Posted: March 2003